Management, Body Systems, and Case Studies in COVID-19

Section A: Introductory chapters and setting the scene<br><br>1. Hand hygiene strategies<br><br>2. Approved vaccines for the COVID-19 pandemic: Linking in future perspectives<br><br>3. Molecular methods for SARS-CoV-2 variant detection<br><br>Section B: Management<br><br>4. Systematic patient assessment for acute respiratory tract ailments (SPARTA): A simple tool to improve outcomes from COVID-19<br><br>5. Point of care ultrasound for coronavirus disease 2019: The multiorgan approach to COVID-19<br><br>6. COVID-19 in patients with inflammatory bowel diseases: Features and guidelines<br><br>7. Management of COVID-19 and clinical nutrition<br><br>8. The management of head and neck cancer in COVID-19<br><br>9. The COVID-19 pandemic: Inventory management and allocation of personal protective<br>equipment<br><br>10. Clinical management in the COVID-19 pandemic: Rheumatic disease<br><br>11. Managing migraines during the COVID-19 pandemic: An Italian experience<br><br>12. Managing acute ischemic stroke in the SARS-CoV-2 pandemic<br><br>13. Impact of the coronavirus disease 2019 pandemic on patients with hypertension<br><br>14. Neurosurgical trauma management during COVID-19 restrictions<br><br>15. The COVID-19 pandemic and management of weight gain: Implications for obesity<br><br>16. COVID-19 and the management of heart failure using telemedicine<br><br>Section C: Guidelines for different treatment clinics<br><br>17. Guidelines for breast imaging in the COVID-19 pandemic<br><br>18. Vaccine-induced (immune) thrombotic thrombocytopenia (VITT): Diagnosis, guidelines,<br>and reporting<br><br>19. Lung cancer in the era of COVID-19<br><br>20. Multisystem inflammatory syndrome in children/pediatric inflammatory multisystem<br>syndrome: Clinical guidelines<br><br>Section D: Impact on the respiratory system<br><br>21. Ground-glass nodules in the lungs of COVID-19 patients<br><br>22. Cardiothoracic imaging in patients affected by COVID-19<br><br>23. Cystic fibrosis and bronchial epithelial cells in SARS-CoV-2 infection<br><br>24. Biomechanics and mechanobiology of the lung parenchyma following SARS-CoV-2 infection<br><br>25. Long noncoding RNA profiling in respiratory specimens from COVID-19 patients<br><br>26. COVID-19 and acute pulmonary embolism<br><br>27. The usefulness of the alveolar-arteriolar gradient during the COVID-19 pandemic<br><br>Section E: Effects on cardiovascular and hematological systems<br><br>28. Cardiac manifestations of COVID-19: An overview<br><br>29. Limb ischemia and COVID-19<br><br>30. Thrombosis and coagulopathy in COVID-19: A new narrative<br><br>31. COVID-19 myocarditis: Features of echocardiography<br><br>32. COVID-19 lockdown and impact on arrhythmias<br><br>33. Cardiometabolic disease and COVID-19: A new narrative<br><br>34. Postrecovery COVID-19 and interlinking diabetes and cardiovascular events<br><br>35. COVID-19 patients and extracorporeal membrane oxygenation<br><br>36. Sars-CoV-2 infection in different hematological patients<br><br>Section F: Effects on body systems<br><br>37. Dermatological reactions associated with personal protective equipment use during<br>the COVID-19 pandemic<br><br>38. Hemodialysis patients, effects of infections by SARS-CoV-2 and vaccine response<br><br>39. Coinfections with COVID-19: A focus on tuberculosis (TB)<br><br>40. Patients with autoimmune liver disease and the impact of Sars-COV-2 infection<br><br>41. COVID-19 severity and nonalcoholic fatty liver disease<br><br>42. Changes in obesity and diabetes severity during the COVID-19 pandemic at Virginia<br>Commonwealth University health system<br><br>43. The diabetic patient and concomitant conditions rhinoorbital-cerebral mucormycosis<br>and COVID-19<br><br>44. Tissue location of SARS-CoV-2 RNA: A focus on bone and implications for skeletal health<br><br>45. Linking between gastrointestinal tract effects of COVID-19 and tryptophan metabolism<br><br>46. Organ damage in SARS-CoV-2 infection in children: A focus on acute kidney injury<br><br>47. Obesity, COVID-19 severity, and mortality<br><br>48. Upper and lower gastrointestinal symptoms and manifestations of COVID-19<br><br>49. The COVID-19 survivors: Impact on skeletal muscle strength<br><br>Section G: Case studies with mini review<br><br>50. A case report: COVID-19 meningoencephalitis and intracranial hemorrhage<br><br>51. Case study: Oral mucosal lesions in patients with COVID-19<br><br>52. Case study: COVID-19 pneumonia presented with cavitary lesions<br><br>53. Case study: Optic neuritis in SARS-CoV-2 infection<br><br>Section H: Resources<br><br>54. Recommended resources relevant to the body systems involvement<br>and management of COVID-19